๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chronic hepatitis B virus infection

โœ Scribed by Paz, M.O.A.; Brenes, F.; Karayiannis, P.; Jowett, T.P.; Scheuer, P.J.; Thomas, H.C.


Book ID
122350568
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
497 KB
Volume
3
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Chronic Hepatitis B Virus Infection
โœ McMahon, Brian J. ๐Ÿ“‚ Article ๐Ÿ“… 2014 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 685 KB
Acyclovir in chronic hepatitis B virus i
โœ Geoffrey M. Dusheiko ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 273 KB ๐Ÿ‘ 2 views

In a previous study a partial inhibition of viral replication was observed in HBeAg-positive patients after acyclovir (ACV) treatment. To assess those results and to evaluate different treatment regimens, a randomized controlled trial with ACV given at 45 mg/kg/day by continuous infusion (in 5 pati

AFP in chronic hepatitis B virus infecti
โœ Yun-Fan Liaw; Anna Lok ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 151 KB ๐Ÿ‘ 2 views

to be controlled for in comparing immunoprophylactic approaches. At present, DNA polymerase activity or HBV DNA is useful for estimating the level of exposure. In an editorial in this issue, Dr. Dienstag pointed out difficulties in comparing the results of two immunoprophylactic regimens conducted a